| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.3 | 5e-10 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.35 | 5e-10 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.3 | 4e-09 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.24 | 5e-09 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.23 | 3e-08 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.4 | 4e-08 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.25 | 1e-07 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-07 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.3 | 4e-07 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.23 | 6e-07 |